Literature DB >> 31724387

Prevalence of Helicobacter pylori Infection in Patients with Chronic Kidney Disease.

Ji Yong Ahn1.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31724387      PMCID: PMC6860031          DOI: 10.5009/gnl19310

Source DB:  PubMed          Journal:  Gut Liver        ISSN: 1976-2283            Impact factor:   4.519


× No keyword cloud information.
There have been some debates about the association of Helicobacter pylori infection and chronic kidney disease (CKD). Pathogenesis of H. pylori infection in patients with CKD is not clearly revealed and there are not enough studies about these two factors. There are several hypothesis which support that kidney disease may reduce H. pylori infection. High level of serum urea nitrogen can contribute to a decreased gastric acid secretion and higher gastric pH which could be the cause of lower prevalence of H. pylori among CKD.1 Inflammatory cytokines are also increased in CKD patients and it can cause gastric mucosal damage, chronic gastritis, and spontaneously eradicate H. pylori.2 In addition, antibiotics, proton pump inhibitors, or H2 receptor antagonists which are used in patients with CKD for long time might be associated with decreased H. pylori infection.3 There are other hypothesis that are contrary to above theories. Some studies showed that high urea concentration makes the gastric mucosa more susceptible to H. pylori and infection rate is higher in uremic patients.4,5 And, in some articles which have studied about peptic ulcer in CKD, the prevalence of H. pylori infection looked lower compare to ulcer in non-CKD patients but real incidence may not be lower.6 Because the incidence of peptic ulcer is higher in CKD patients with various causes except H. pylori infection.7 In nationwide study of Taiwan, H. pylori infection rate is lower in peptic ulcer disease patients with CKD and end-stage renal disease (ESRD) than in those without CKD.6 On the contrary, recent meta-analysis studies showed no relation between H. pylori infection and CKD nor ESRD.8,9 However, those previous meta-analysis about the association between H. pylori infection and kidney disease have some selection biases. In this research,10 authors tried to minimize bias of previous meta-analyses and showed the results about the prevalence of H. pylori infection in patients with CKD. In this issue of Gut and Liver, Shin et al.10 included many articles compared to previous studies using systematic reviews and narrowed inclusion criteria to increase the accuracy of the results. Studies with only CKD patients were enrolled and other studies which have vague inclusion criteria including renal transplant recipients, diabetic nephropathy, or pediatric population were excluded. Authors compared the prevalence of H. pylori infection between CKD patients and control first, then showed subgroup analyses according to the modifiers. In the 47 case-control or cross-sectional studies, CKD patients were 4,084 and controls without CKD were 6,908, and total prevalence of H. pylori infection in CKD patients was 48.2% and in controls was 59.3%. Pooled analysis using 34 studies with same study design and statistical models supported significantly lower rate of H. pylori infection in CKD patients (odd ratio, 0.64; 95% confidential interval, 0.52 to 0.79). This meta-analysis10 showed lower infection rate of H. pylori in CKD patient with or without dialysis compare to non-CKD patients. Based on this research, there are some interesting points and further considerations. In this study, subgroup analysis showed the different results according to the methodological quality of included studies and significantly lower prevalence rate of H. pylori infection in CKD patients compare to controls was revealed in high qualified studies. In previous study which reported negative association of H. pylori with CKD,8 author showed trend of decreased risk of H. pylori infection in patients with CKD in subgroup which had lower heterogeneity. These factors can be thought that, if studies can be focused to the adult CKD patients without renal transplant recipient or diabetes mellitus nephropathy, the prevalence of H. pylori infection may be clearly lower in CKD patients. This kind of clear result could pave the way for researchers to focus on the next step such as to clarify the reason of decreasing H. pylori infection in CKD patients. This study, which was performed using statistical techniques of great effort, has important clinical meaning because authors found that H. pylori infection rate is lower in CKD patients compare to non-CKD patients. And they gave a message of importance about the well-designed study. Based on these results, further studies are expected to clearly the association between H. pylori and renal function and finally to contribute reducing the H. pylori infection.
  10 in total

Review 1.  Association of Helicobacter pylori with Chronic Kidney Diseases: A Meta-Analysis.

Authors:  Karn Wijarnpreecha; Charat Thongprayoon; Pitchaphon Nissaisorakarn; Veeravich Jaruvongvanich; Kiran Nakkala; Ridhmi Rajapakse; Wisit Cheungpasitporn
Journal:  Dig Dis Sci       Date:  2017-03-06       Impact factor: 3.199

2.  Lower Helicobacter pylori infection rate in chronic kidney disease and end-stage renal disease patients with peptic ulcer disease.

Authors:  Shen-Shong Chang; Hsiao-Yun Hu
Journal:  J Chin Med Assoc       Date:  2014-06-03       Impact factor: 2.743

3.  Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study.

Authors:  G-Y Tseng; H-J Lin; C-T Fang; H-B Yang; G-C Tseng; P-C Wang; T-L Hung; Y-C Deng; Y-T Cheng; C-H Huang
Journal:  Aliment Pharmacol Ther       Date:  2007-09-15       Impact factor: 8.171

4.  Helicobacter pylori-specific IgG in chronic haemodialysis patients: relationship of hypergastrinaemia to positive serology.

Authors:  F Luzza; M Imeneo; M Maletta; I Mantelli; D Tancre; G Merando; L Biancone; F Pallone
Journal:  Nephrol Dial Transplant       Date:  1996-01       Impact factor: 5.992

5.  Significantly lower prevalence of Helicobacter pylori in uremic patients than in patients with normal renal function.

Authors:  D Jaspersen; W Fassbinder; P Heinkele; H Kronsbein; W Schorr; C Raschka; M Brennenstuhl
Journal:  J Gastroenterol       Date:  1995-10       Impact factor: 7.527

6.  Gastrin and gastric acid secretion in renal failure.

Authors:  R I Wesdorp; H A Falcao; P B Banks; J Martino; J E Fischer
Journal:  Am J Surg       Date:  1981-03       Impact factor: 2.565

7.  Campylobacter pyloridis, urease, hydrogen ion back diffusion, and gastric ulcers.

Authors:  S L Hazell; A Lee
Journal:  Lancet       Date:  1986-07-05       Impact factor: 79.321

8.  Association between Helicobacter pylori and end-stage renal disease: A meta-analysis.

Authors:  Karn Wijarnpreecha; Charat Thongprayoon; Pitchaphon Nissaisorakarn; Natasorn Lekuthai; Veeravich Jaruvongvanich; Kiran Nakkala; Ridhmi Rajapakse; Wisit Cheungpasitporn
Journal:  World J Gastroenterol       Date:  2017-02-28       Impact factor: 5.742

9.  Helicobacter pylori Infection in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  Suk Pyo Shin; Chang Seok Bang; Jae Jun Lee; Gwang Ho Baik
Journal:  Gut Liver       Date:  2019-11-15       Impact factor: 4.519

10.  Helicobacter pylori Infection in Dialysis Patients: A Meta-Analysis.

Authors:  Min Gu; Shuping Xiao; Xiaolin Pan; Guoxin Zhang
Journal:  Gastroenterol Res Pract       Date:  2013-11-07       Impact factor: 2.260

  10 in total
  2 in total

1.  Comparison of endoscopic and pathological findings of the upper gastrointestinal tract in transplant candidate patients undergoing hemodialysis or peritoneal dialysis treatment: a review of literature.

Authors:  Mehmet Usta; Alparslan Ersoy; Yavuz Ayar; Gökhan Ocakoğlu; Bilgehan Yuzbasioglu; Emrullah Düzgün Erdem; Omer Erdogan
Journal:  BMC Nephrol       Date:  2020-10-22       Impact factor: 2.388

2.  The Herbal Formula Granule Prescription Mahuang Decoction Ameliorated Chronic Kidney Disease Which Was Associated with Restoration of Dysbiosis of Intestinal Microbiota in Rats.

Authors:  Yao Ming; Sijing Cheng; Wen Long; Hong-Lian Wang; Chuanlan Xu; Xiaoyu Liu; Qiong Zhang; Sha Zhao; Xia Zou; Junming Fan; Li Wang; Hongchun Shen
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-23       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.